ALNYLAM PHARMACEUTICALS, INC.【ALNY】Balance sheet

Market cap

$51.9B

P/E ratio

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	75	70	51	53	75	181	194	645	420	547	497	820	866	815	969
Marketable securities, current	159	76	71	193	527	848	424	1,045	663	975	1,333	1,549	1,298	1,616	1,720
Total cash & short-term investments	233	146	123	246	602	1,029	618	1,691	1,083	1,522	1,830	2,369	2,164	2,430	2,689
Accounts receivable, net	-	-	-	-	-	-	-	-	19	43	102	199	238	328	405
Inventories	-	-	-	-	-	-	-	-	24	56	75	86	129	89	79
Total current assets	254	152	125	254	746	1,105	672	1,765	1,201	1,716	2,615	2,809	2,692	2,983	3,295
Property, plant and equipment, net	18	15	20	16	22	28	115	182	321	425	465	502	523	526	503
Marketable securities, non-current	117	114	103	105	280	252	325	14	-	-	-	-	-	-	-
Total non-current assets	139	130	162	167	333	281	591	230	374	679	792	835	854	847	945
Total assets	393	282	288	421	1,080	1,387	1,263	1,995	1,575	2,395	3,407	3,643	3,546	3,830	4,240
Accounts payable	9	6	4	6	15	17	54	28	60	50	52	73	98	56	88
Total current liabilities	102	81	48	54	95	62	132	144	179	353	585	696	768	968	1,186
Total non-current liabilities	133	83	105	96	48	60	211	84	93	604	1,806	2,359	2,937	3,083	2,987
Total liabilities	235	164	153	150	143	122	343	228	273	956	2,391	3,055	3,705	4,051	4,173
Common stock and paid-in capital	0	0	1	1	1	1	1	1	1	1	1	1	1	-	1
Retained earnings	-343	-401	-507	-596	-957	-1,247	-1,657	-2,148	-2,841	-3,727	-4,585	-5,438	-6,569	-7,010	-7,288
Stockholders' equity	158	118	134	270	936	1,265	920	1,766	1,302	1,439	1,016	588	-158	-221	67
Working capital	-	-	-	-	-	-	-	-